What is Kindbody?
Founded in 2018 and headquartered in New York City, Kindbody operates at the intersection of health and technology. The company provides a comprehensive suite of services, including fertility treatments, gynecology, and holistic wellness, delivered through a network of tech-enabled clinics. By digitizing the patient experience and streamlining access to reproductive care, Kindbody addresses critical gaps in the traditional healthcare landscape. Their market position is defined by a commitment to transparency, accessibility, and high-quality clinical outcomes, effectively disrupting the conventional fertility industry through a vertically integrated, patient-centric approach.
How much funding has Kindbody raised?
Kindbody has raised a total of $234M across 5 funding rounds:
Series A
$15M
Series B
$32M
Series C
$62M
Private Equity
$100M
Private Equity
$25M
Series A (2019): $15M, investors not publicly disclosed
Series B (2020): $32M led by Perceptive Advisors, Claritas Capital, Freemark Capital, Goodgrower, RRE, Rock Springs Capital, and GV
Series C (2021): $62M supported by Eldridge Industries, Bramalea Partners, Theresa Sexton, and Monashee Investment Management
Private Equity (2023): $100M featuring Perceptive Advisors
Private Equity (2023): $25M backed by JPMorgan Chase
Key Investors in Kindbody
Perceptive Advisors
Founded in 1999 and based in New York, NY, Perceptive Advisors is an investment firm managing around $7 billion in assets, focused on funding innovative healthcare and life sciences technologies.
GV
GV is a venture capital firm founded in 2001 that invests across multiple stages and sectors, focusing on enterprise solutions, life sciences, and frontier technology innovations.
Eldridge Industries
Eldridge Industries operates as a diversified asset management and insurance holding company, managing substantial capital across multiple investment and insurance platforms.
What's next for Kindbody?
With the infusion of capital from its most recent financing, Kindbody is well-positioned to accelerate its national footprint and enhance its digital health infrastructure. The strategic focus will likely center on scaling clinic operations in key metropolitan markets and deepening its enterprise-level partnerships. As the company matures, the emphasis will shift toward optimizing operational efficiencies and expanding its service offerings to meet the evolving needs of its patient base. This phase of growth is critical for maintaining a competitive edge in the rapidly consolidating fertility and wellness market, ensuring that Kindbody remains a preferred provider for both individual patients and corporate health programs.
See full Kindbody company page
